CGM in the Real T2D World
from CME
Faculty: Jennifer Goldman, PharmD, CDCES, BC-ADM-FCCP Faculty: Francisco Javier Ampudia-Blasco, MD, PhD Continuous glucose monitoring (CGM) is still recommended for all individuals with diabetes, including those with type 2 diabetes (T2D). Despite this, its use in managing T2D has not been as widespread as expected. New evidence has recently highlighted the benefits of CGM for people with T2D. Join our panel of international experts as they explore these findings and discuss how to incorporate them into clinical practice.
Embed this episode
No transcript yet.